Logo (Sodium Acetate 01)
Sodium Acetate Injection, Solution, Concentrate
Product Images NDC 0409-7299
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Acetate (NDC 0409-7299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (20 mL Vial Label)
This is a description of 40 mEq/20mL single-dose Sodium Acetate injection, which must be diluted for intravenous use. Each mL contains 164 mg of sodium acetate, anhydrous and may contain acetic acid for pH adjustment. It is sterile, nonpyrogenic, and has a pH of 6.5. The usual dosage information is provided in the insert. The product is distributed by Hospira, Inc., and is stored at 20 to 25°C (68 to 77°F). Additionally, it contains no more than 200 mcg/L of aluminum.*
Principal Display Panel (20 mL Vial Tray)
This text appears to be a label or description of a pharmaceutical product. It indicates that each mL contains sodium acetate, anhydrous, and may contain et xid for pH adjustment. The recommended dosage is stated as 4mosmol/mL with a pH of 6.5. The text also includes cautionary information that the product must be diluted. Additionally, the product is indicated for intravenous use with a concentration of 40 mEq/20 mL. The product is supplied in 20 mL single-dose vials.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
